These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37356253)
1. Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines. Binderup A; Galli A; Fossat N; Fernandez-Antunez C; Mikkelsen LS; Rivera-Rangel LR; Scheel TKH; Fahnøe U; Bukh J; Ramirez S Virology; 2023 Aug; 585():179-185. PubMed ID: 37356253 [TBL] [Abstract][Full Text] [Related]
2. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664 [TBL] [Abstract][Full Text] [Related]
3. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure. Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067 [TBL] [Abstract][Full Text] [Related]
11. Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication. Yau WL; Nguyen-Dinh V; Larsson E; Lindqvist R; Överby AK; Lundmark R J Virol; 2019 Sep; 93(18):. PubMed ID: 31243132 [No Abstract] [Full Text] [Related]
12. Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Eyer L; Zouharová D; Širmarová J; Fojtíková M; Štefánik M; Haviernik J; Nencka R; de Clercq E; Růžek D Antiviral Res; 2017 Jun; 142():63-67. PubMed ID: 28336346 [TBL] [Abstract][Full Text] [Related]
13. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus. Kuznetsova N; Siniavin A; Butenko A; Larichev V; Kozlova A; Usachev E; Nikiforova M; Usacheva O; Shchetinin A; Pochtovyi A; Shidlovskaya E; Odintsova A; Belyaeva E; Voskoboinikov A; Bessonova A; Vasilchenko L; Karganova G; Zlobin V; Logunov D; Gushchin V; Gintsburg A PLoS One; 2023; 18(5):e0284823. PubMed ID: 37163522 [TBL] [Abstract][Full Text] [Related]